modified double elimination protocol. Upon treatment of the
amino anion generated from 12 with LHMDS in the presence
of chloroacetamide 13,14 the intramolecular Michael-type
addition and in situ alkylation of the resulting carbanion
occurred smoothly to provide compound 14 in good yield.15
In conclusion we have shown a novel route to synthesize
indole derivatives from easily accessible sulfones by a
sequence of two one-pot procedures. The overall yields are
high, in general, and the products are free from the residues
of transition metal catalysts, offering a practical means for
the indole synthesis. Efforts to synthesize other heterocycles
are currently in progress.
Table 1. Synthesis of 2,3-Disubstituted Indoles
yield
electrophile
MeI (3 equiv)
R
product (%)a
CH3
11a
11b
11c
11d
11e
11f
82
86
84
84
81
86
85
C2H5I (4 equiv)
C3H7I (4 equiv)
C2H5
C3H7
Supporting Information Available: Experimental details
and characterizaton data. This material is available free of
allyl iodide (4 equiv)
BrCH2CO2C2H5 (4 equiv)
CH2CHdCH2
CH2CO2C2H5
ClCH2CON(C2H5)2 (4 equiv) CH2CON(C2H5)2
benzoyl chlorideb (5 equiv)
COPh
11g
OL051826E
a Isolated yield. b Reagents and conditions: (i) LHMDS (1.5 equiv), 0
°C, 1 h to room temperature, 10 min, (ii) PhCOCl (5 equiv), rt, 1 h, (iii)
LHMDS (5 equiv), rt, 1 h.
(13) Kozikowski, A. P.; Ma, D.; Brewer, J.; Sun, S.; Costa, E.; Romeo,
E.; Guidotti, A. J. Med. Chem. 1993, 36, 2908.
(14) Seguin H.; Gardette, D.; Moreau, M. F.; Madelmont, J. C.; Gramai,
J. C. Synth. Commun. 1998, 28, 4257.
(15) Synthesis of 12: BuLi (1.33 M in hexane, 1.45 mL, 1.93 mmol)
was added to a THF solution (20 mL) of sulfone 9 (0.636 g, 1.76 mmol)
at -78 °C, and the mixture was stirred for 30 min. 4-Chlorobenzaldehyde
(0.296 g, 2.11 mmol) in THF (8 mL) was added dropwise at this
temperature. After an additional 1 h, ClP(O)(OEt)2 (0.305 mL, 2.11 mmol)
was added at -78 °C and the mixture was stirred at room temperature for
2 h. Potassium tert-butoxide (0.645 g, 5.28 mmol) was added at 0 °C. After
the mixture had been stirred at the same temperature for 1 h, the solvent
was evaporated and the residue was dissolved in a premixed solution of
ethyl acetate (29.4 mL)/12 M HCl (12.6 mL) and stirred at room temperature
for 2 h. The reaction mixture was neutralized with solid NaHCO3, extracted
with ethyl acetate, dried over MgSO4, and filtered. The solvent was
evaporated and the residue was chromatographed (2.5:7.5 ethyl acetate/
hexane) to give 0.614 g of 12 (91%) as a yellow solid: 1H NMR (500
MHz, CDCl3) δ 7.99 (s, 1H), 7.65 (dd, 2H, J ) 8.5, 1.5 Hz), 7.57 (m, 1H),
7.42 (t, 2H, J ) 8.5 Hz), 7.28 (m, 1H), 7.18 (d, 2H, J ) 8.5 Hz), 7.10 (d,
2H, J ) 8.5 Hz), 6.58 (d, 1H, J ) 8.0 Hz), 6.55 (dt, 1H, J ) 7.0, 1.0 Hz),
alkylation reagents with an ester or amide function were
employable as well. It is to be noted that acylation also works
smoothly because 3-acyl derivatives constitute an important
class of the indole derivatives.
To exemplify the usefulness of the present protocol, we
have chosen compound 14, which is one of the better ligands
for the antineophonic mitochondrial DBI receptor complex13
(Scheme 5). Thus, the vinyl sulfone 12 was synthesized
starting from 9 and 4-chlorobenzaldehyde according to our
6.47 (dd, 1H, J ) 7.0, 1.0 Hz), 3.97 (br, 1H), 2.57 (d, 3H, J ) 5.0 Hz); 13
C
Scheme 5
NMR (125 MHz, CDCl3) δ 147.9, 139.0, 138.2, 138.0, 136.5, 133.3, 131.4,
131.2, 131.1, 131.0, 128.9, 128.8, 128.6, 116.8, 115.0, 110.4, 30.4. Synthesis
of 14:13 A 50 mL flask was charged with 12 (0.306 g, 0.79 mmol) in THF
(15 mL) and cooled to 0 °C. LHMDS (1 M in THF, 1.20 mL, 1.19 mmol)
was added slowly. After the mixture had been stirred at 0 °C for 1 h, and
then at room temperature for 10 min, 13 (0.566 g, 3.18 mmol) was added.
After the mixture had been stirred at room temperature for 1 h, the reaction
was quenched by the addition of aqueous NH4Cl and extracted with ethyl
acetate. The extract was dried over MgSO4 and filtered. The solvent was
evaporated and chromatographed (3:7 ethyl acetate/hexane) to give 0.244
g of 14 (80%) as a colorless solid: 1H NMR (500 MHz, CDCl3) δ 7.68 (d,
1H, J ) 7.5 Hz), 7.47 (d, 2H, J ) 8.5 Hz), 7.40 (d, 2H, J ) 8.5 Hz), 7.33
(d, 1H, J ) 8.5 Hz), 7.25 (m, 1H), 7.14 (t, 1H, J ) 8.0 Hz), 3.68 (s, 2H),
3.60 (s, 3H), 3.26 (t, 2H, J ) 7.5 Hz), 3.10 (t, 2H, J ) 7.5 Hz), 1.53 (m,
4H), 0.83 (t, 3H, J ) 7.5 Hz), 0.74 (t, 3H, J ) 7.5 Hz); 13C NMR (125
MHz, CDCl3) δ 170.7, 137.3, 137.1, 134.3, 131.8, 129.9, 128.6, 127.6,
122.0, 119.6, 119.4, 109.3, 107.6, 49.6, 47.8, 30.9, 30.5, 22.1, 20.8, 11.3,
11.0.
a One isomer (geometry not determined).
Org. Lett., Vol. 7, No. 21, 2005
4643